Celgene’s shares rose after the biotech company announced an accelerated stock repurchase, but the pace of Celgene’s buybacks shouldn’t do much to reassure investors.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Thu, 05/24/2018 - 11:27am
Celgene’s shares rose after the biotech company announced an accelerated stock repurchase, but the pace of Celgene’s buybacks shouldn’t do much to reassure investors.